Yes, thioredoxin reductase can be inhibited by various compounds, which can disrupt the redox balance within cells leading to apoptosis, particularly in cancer cells. Platinum-based drugs, such as cisplatin, and gold compounds are known inhibitors. These inhibitors covalently modify the enzyme, rendering it inactive.
